Vapor phase hydrogen peroxide has been used for decades as a surface decontaminant in pharma/biotech, but there has been little guidance on how to establish the parameters. Here's an industry consensus from BioPhorum.
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
- Want More Sustainable Biopharma Packaging? Try These Levers
- What Europe's Draft Annex 22 Actually Asks Of Human Oversight Of AI
- Fine-Tuning Bioseparation Column Geometry With 3D-Printed Monoliths
- How Is Your Glass Supplier Adapting To Europe's Energy Crisis?
- The EU Overhauls Pharma Laws: What You Need To Know
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Automated, Scalable, And GMP-Compliant MSC And EV Manufacturing With TheraPEAK® MSC-VIVO™
MSC and MSC-EV manufacturing at clinical scale depends on moving from serum-supplemented 2D culture to xeno-free, automated 3D processes that keep cell phenotype, multipotency, and vesicle quality intact.
-
Engineering Precision In Genetic Medicines
Explore how protein discovery, PAM engineering, and AI-guided optimization can expand target coverage, improve editing specificity, and address challenging therapeutic applications.
-
Simpler, Faster, Cheaper Advanced Therapy Manufacturing
Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.
-
Fluorescent Bacterial Colony Selection
Fluorescent reporter genes simplify screening bacterial transformants. Discover a system that automates colony picking to enhance efficiency and precision with fluorescence imaging.
-
USP <665> Becomes Official On May 1, 2026. Are You Ready?
With USP <665> becoming official on May 1, 2026, proactive preparation is essential to ensure compliance and prevent delays, regulatory observations, or supply chain disruptions.
-
Human Platelet Lysate (hPL) Improves Expansion Of MSCs
Learn how human platelet lysate significantly improves mesenchymal stromal/stem cell expansion and eliminates the need for plate coating, boosting yield without altering cell phenotype.
-
Turnkey Dismantling, Modification, And Relocation Of A Multi-Glove Isolator System
Strategic equipment relocation and retrofitting can reduce capital costs by fifty percent and save months in lead time. Learn how to modernize legacy systems while maintaining full GMP compliance.
-
Ensuring Supply Through Speed And Transparency
Through speed, transparency, and close collaboration, the pharmaceutical company was able to switch vendors seamlessly, maintaining virtually uninterrupted manufacturing operations.
-
Master The Art Of Pipetting And Learn How To Perform Serial Dilutions
Accurate serial dilutions depend on more than calculations. Learn how mixing, tip handling, and workflow consistency influence accuracy, as well as how small adjustments can improve reproducibility.
-
A Practical Guide To Harnessing The Value Of APAC For Global Trial Success
As Phase III costs and complexity rise, APAC offers faster enrollment, lower costs, and market access advantages, but capturing that value requires early planning and in-region expertise.
NEWSLETTER ARCHIVE
- 11.10.26 -- Implementing AI And Digital Twins In Bioprocessing With Will Olughu, Ph.D.
- 11.10.26 -- How To Stand Up A Hospital-Based CAR-T Manufacturing Network
- 11.09.26 -- Is Your Single-Use Process Built To Perform?
- 11.09.26 -- Building A Fill-Finish Strategy That Lasts
- 11.09.26 -- Why You Should Measure Comparability Debt Before Ever Starting A Study
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 2
- Exploring Earlier Gene Editing For Children With Dr. Haydar Frangoul, Part 1
- Earlier Decisions, Better Processes Required For Automating Autologous CAR T Manufacturing
- Why In Vivo Innovation, Regulatory Convergence Will Help Shape CGT's Next Chapter
- Inside The Next Phase In Autoimmune CAR T From Meeting On The Mesa 2026
EDITORIAL COLLECTIONS KNOWLEDGE CENTER
Our Editorial Collections examine today’s biggest scientific, operational, and patient-centered drug delivery issues. These collections help companies navigate complex development decisions with in-depth analysis, real-world examples, and guidance from industry experts
More Editorial Collections

